MRNA and PFE Related Headlines
Go Back- Moderna jumps as vaccine shows benefit in head and neck cancer in early study
- Midday movers: Coinbase falls; Pfizer and Moderna rise
- 2 reasons why Moderna stock is surging today
- Moderna (MRNA) Climbs 9.4%
- Comprehensive study links COVID vaccines to rare but notable adverse effects
- Midday movers: Oracle, Moderna and more
- BioNTech says EU Patent Office declared Moderna patent invalid
- Stock Market Today: Dow ends higher on tech gains as earnings season to heat up
- S&P 500 jumps as big tech soaks up demand, shrugs off rising Treasury yields
- Moderna (MRNA) 'remains comfortable' with Covid vaccine guidance range after Pfizer slashes forecast
- Apple, Nvidia and Pfizer fall premarket; Lululemon rises
- Moderna (MRNA) declines on concerns about takeup of Covid booster
- Stock market today: Dow falls a second day while tech stocks shake off inflation
- Tech stocks rise after inflation report as investors look to Fed meeting
- Stocks are rising after inflation report; Fed meeting in focus
- U.S. stocks are rising after inflation report; Fed meeting in focus
- US CDC panel advocates widespread adoption of updated COVID-19 vaccines
- Roku, Toast, Gitlab and Moderna rise premarket; Southwest Airlines falls
- COVID-19 vaccine stocks gain as Biden expected to request new vaccine, recommended for all
- COVID-19 vaccine stocks gain pre-open as Biden to request new vaccine, recommended for all
- US CDC says new COVID lineage could cause infections in vaccinated individuals
- Why Moderna (MRNA) could see COVID-19 vaccine share gains this fall
- Moderna revenue beats estimates despite COVID vaccine sales slump
- EU To Announce Deal With Pfizer, Others To Reserve Vaccines For Future Pandemic - Reuters
- FDA Advisers Back Updating Covid Shots To Target XBB Subvariant - Bloomberg
- BioNTech SE (BNTX) on Watch Following NYT Report "Pancreatic Cancer Vaccine Shows Promise in Small Trial"
- First Republic, Fed meeting, Apple earnings - what's moving markets
